International Journal of Medical and Pharmaceutical Research
2026, Volume-7, Issue 5 : 67-70
Case Report
Rare Case of Culture Negative Native Tricuspid Valve Infective Endocarditis- Serial HRCT Helped the Management Problem
 ,
 ,
Received
Sept. 17, 2026
Accepted
Oct. 8, 2026
Published
Oct. 26, 2026
Abstract

Background: Infective endocarditis (IE) is an acute or subacute endocardial infection caused by bacterial, viral or fungal microorganisms. Right-sided native valve infective endocarditis refers to IE involving the tricuspid or pulmonic valve; isolated right-sided IE accounts for approximately 10 percent of all IE cases, most commonly associated with a history of immunocompromised status and drug abuse; concomitant left-sided IE account for approximately 13 percent of all IE cases.

Case Summary: A 20-year-old male presented to medicine ward with high-grade fever, chills, and dry cough for 10 days. He had no history of intravenous drug use, previous hospitalizations, cardiac disease, or any history suggestive of immunocompromise status. Upon admission, his vitals showed tachycardia (HR 110/min), mild hypoxia (SpO2 92%), and low blood pressure (BP 100/64 mm Hg). Physical examination revealed raised JVP with prominent veins, and decreased breath sounds in the bilateral lower lung fields.(Figure 1,2)

Conclusion- This is a case of fulminant staphylococcus aureus native tricuspid valve endocarditis with pulmonary complication. Previously reported cases of native tricuspid valve endocarditis were with a history of IV drug abuse or prolonged central I.V line or immunocompromised and often culture positive.

Keywords
SUMMARY

A 20-year-old male with a history of intravenous drug use presented with a rare case of culture-negative native tricuspid valve infective endocarditis (IE). The patient had persistent fever, dyspnea, and weight loss. Clinical evaluation revealed tachycardia, peripheral edema, and a systolic murmur at the left lower sternal border. Transthoracic echocardiography showed a large, mobile vegetation on the tricuspid valve without significant regurgitation. High-resolution computed tomography (HRCT) revealed multiple bilateral septic emboli, prompting early empiric antibiotic therapy. This case is unique as it does not have a history of drug abuse or prolonged central I.V line, and culture is negative. Inappropriate antibiotic use can lead to relapse of symptoms and antibiotic resistance, making it crucial to diagnose and treat the case.

 

BACKGROUND

Infective endocarditis (IE) is an acute or subacute endocardial infection caused by bacterial, viral or fungal microorganisms. Right-sided native valve infective endocarditis refers to IE involving the tricuspid or pulmonic valve; isolated right-sided IE accounts for approximately 10 percent of all IE cases, most commonly associated with a history of immunocompromised status and drug abuse; concomitant left-sided IE account for approximately 13 percent of all IE cases.[1,2] Diagnosis and treatment of IE becomes very difficult with prior inappropriate antibiotics. We report a case of culture-negative and drug-resistant native tricuspid valve endocarditis with pulmonary complications without immunosuppression or history of drug abuse.

 

CASE SUMMARY

A 20-year-old male presented to medicine ward with high-grade fever, chills, and dry cough for 10 days. He had no history of intravenous drug use, previous hospitalizations, cardiac disease, or any history suggestive of immunocompromise status. Upon admission, his vitals showed tachycardia (HR 110/min), mild hypoxia (SpO2 92%), and low blood pressure (BP 100/64 mm Hg). Physical examination revealed raised JVP with prominent veins, and decreased breath sounds in the bilateral lower lung fields.(Figure 1,2)

 

Figure 1 ECG suggestive of sinus tachycardia and 2D echo showing vegetation at Tricuspid valve

 

Figure 2 HRCT thorax at first admission suggestive of Bilateral pleural effusion and consolidation

 

Laboratory findings included Haemoglobin 12.6 gm%, leukocytosis (TLC 13,400/mm³), elevated CRP, and ESR. HRCT thorax showed bilateral pleural-based consolidations with minimal pleural effusion. A 2D echocardiogram revealed a 1.2 cm × 1.2 cm vegetation on the tricuspid valve, suggesting infective endocarditis (IE). Blood cultures were negative. Empiric IV vancomycin and ceftriaxone were started, and the patient became afebrile after 4-5 days, but he discontinued antibiotics 4 days after discharge from department of medicine.

 

The patient relapsed with fever, dry cough, breathlessness, chest pain and palpitations a few days later. On readmission to cardiology ward, his laborartory findings were anaemia (Hb 6.8 gm%), leukocytosis (TLC 21400), and raised ESR and CRP. Repeat blood cultures were negative, and after 10 days of IV antibiotics, including linezolid (due to elevated creatinine), his symptoms persisted. A repeat HRCT showed bilateral consolidation, bullae, and right-sided pneumothorax, likely from Staphylococcus aureus. Antibiotics were switched to cotrimoxazole DS for suspected drug-resistant staphylococcal infection. The patient became afebrile after 4 days, with resolution of respiratory symptoms. A repeat HRCT after 10 days showed resolution of pneumothorax and bullae, and cotrimoxazole was continued for another 3 weeks. The patient was discharged with full recovery.(Figure 3, 4)

 

Figure 3 Repeat HRCT suggestive of Bilateral pneumatocele

 

Figure 4 Repeat HRCT suggestive of Bilateral pneumatocele and pneumothorax

 

DISCUSSION

The patient, who had negative blood cultures due to prior antibiotic use, had bilateral consolidation, bullae, and pneumothorax on serial HRCT. These findings suggested infection by Staphylococcus aureus, Klebsiella, Haemophilus, Streptococcus pneumoniae, or Pneumocystis jirovecii. Pneumocystis was ruled out due to the absence of history suggestive of immunodeficiency and negative HIV serology. Given that Staphylococcus aureus is a common cause of right-sided infective endocarditisas well as pneumonia associated with pneumatocele, the case was suspected to be drug-resistant Staphylococcus aureus infection, and cotrimoxazole was initiated.[3-5]

 

CONCLUSION-

This is a case of fulminant staphylococcus aureus native tricuspid valve endocarditis with pulmonary complication. Previously reported cases of native tricuspid valve endocarditis were with a history of IV drug abuse or prolonged central I.V line or immunocompromised and often culture positive. This case is unique in the sense that it does not have a history of drug abuse/IV catheterization, or any evidence of immunosuppression and culture is negative. Thus, in conclusion, isolated right sided infective endocarditis may rarely occur in a patient without immunodeficiency or history of drug abuse/prolong IV catheterisation; inappropriate antibiotic use in case of infective endocarditis can lead to relapse of symptoms and antibiotic resistance which may lead to difficulty in further management of patient; suspected case of culture-negative native tricuspid valve infective endocarditis with a pulmonary complication, a serial HRCT thorax finding may be helpful to diagnose possible causative organisms and can be treated accordingly.

       

REFERENCES-

  1. Chahoud J, Sharif Yakan A, Saad H, Kanj SS. Right-Sided Infective Endocarditis and Pulmonary Infiltrates: An Update. Cardiol Rev. 2016 Sep-Oct;24(5):230-7.
  2. Akinosoglou K, Apostolakis E, Marangos M, Pasvol G. Native valve right sided infective endocarditis. Eur J Intern Med. 2013 Sep;24(6):510-9.
  3. Singh S, Goel A. Native tricuspid valve endocarditis presenting as pyrexia of unknown origin. J Postgrad Med. 2023 Apr-Jun;69(2):105-107.
  4. José F. Varona and Juan M. Guerra Tricuspid Valve Endocarditis in a Nonaddicted Patient Without Predisposing Myocardiopathy Rev Esp Cardiol 2004;57(10):993-6
  5. Habtewold Shibru et al. Isolated native tricuspid valve endocarditis in a nonintravenous drug user. Case Reports in Cardiology Vol. 2020,8812597
Recommended Articles
Research Article Open Access
Clinico-Pathological Profile of Anemia in Children in A Tertiary Care Centre in North India: An Observational Study
2026, Volume-7, Issue 5 : 62-66
Research Article Open Access
Computer and Pharmaceutical Software in Pharmacy and Pharma Industries
2026, Volume-7, Issue 5 : 40-53
Research Article Open Access
Gastroprotective Role of Mogrosides from Siraitia Grosvenorii Against Ethanol-Induced Gastric Ulcer
2026, Volume-7, Issue 5 : 26-39
Research Article Open Access
Sociodemographic Characteristics and Psychosocial Stressors Among Patients with Dissociative [Conversion] Disorder: A Cross-Sectional Study
2026, Volume-7, Issue 5 : 54-61
International Journal of Medical and Pharmaceutical Research journal thumbnail
Volume-7, Issue 5
Citations
4 Views
8 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
facebook twitter linkedin mendeley research-gate
© Copyright | International Journal of Medical and Pharmaceutical Research | All Rights Reserved